COLOPLAST-B (CBHD.DE) Stock Fundamental Analysis
FRA:CBHD - Deutsche Boerse Ag - DK0060448595 - Common Stock - Currency: EUR
We assign a fundamental rating of 5 out of 10 to CBHD. CBHD was compared to 58 industry peers in the Health Care Equipment & Supplies industry. CBHD has an excellent profitability rating, but there are some minor concerns on its financial health. CBHD has a correct valuation and a medium growth rate.
1. Profitability
1.1 Basic Checks
CBHD had positive earnings in the past year.
In the past year CBHD had a positive cash flow from operations.
Each year in the past 5 years CBHD has been profitable.
Each year in the past 5 years CBHD had a positive operating cash flow.
1.2 Ratios
CBHD has a Return On Assets of 9.45%. This is amongst the best in the industry. CBHD outperforms 86.21% of its industry peers.
Looking at the Return On Equity, with a value of 25.33%, CBHD belongs to the top of the industry, outperforming 93.10% of the companies in the same industry.
CBHD's Return On Invested Capital of 15.63% is amongst the best of the industry. CBHD outperforms 96.55% of its industry peers.
The Average Return On Invested Capital over the past 3 years for CBHD is significantly above the industry average of 8.41%.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.45% | ||
| ROE | 25.33% | ||
| ROIC | 15.63% |
ROA(3y)11%
ROA(5y)18.91%
ROE(3y)37.52%
ROE(5y)45.66%
ROIC(3y)16.81%
ROIC(5y)28.33%
1.3 Margins
Looking at the Profit Margin, with a value of 16.35%, CBHD belongs to the top of the industry, outperforming 87.93% of the companies in the same industry.
CBHD's Profit Margin has declined in the last couple of years.
CBHD has a Operating Margin of 26.90%. This is amongst the best in the industry. CBHD outperforms 96.55% of its industry peers.
In the last couple of years the Operating Margin of CBHD has declined.
Looking at the Gross Margin, with a value of 67.52%, CBHD is in the better half of the industry, outperforming 72.41% of the companies in the same industry.
CBHD's Gross Margin has been stable in the last couple of years.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | 26.9% | ||
| PM (TTM) | 16.35% | ||
| GM | 67.52% |
OM growth 3Y-6.25%
OM growth 5Y-2.74%
PM growth 3Y-9.04%
PM growth 5Y-2.84%
GM growth 3Y-0.46%
GM growth 5Y-0.05%
2. Health
2.1 Basic Checks
The Return on Invested Capital (ROIC) is well above the Cost of Capital (WACC), so CBHD is creating value.
Compared to 1 year ago, CBHD has more shares outstanding
Compared to 5 years ago, CBHD has more shares outstanding
Compared to 1 year ago, CBHD has a worse debt to assets ratio.
2.2 Solvency
An Altman-Z score of 4.36 indicates that CBHD is not in any danger for bankruptcy at the moment.
CBHD has a Altman-Z score of 4.36. This is amongst the best in the industry. CBHD outperforms 81.03% of its industry peers.
The Debt to FCF ratio of CBHD is 4.64, which is a neutral value as it means it would take CBHD, 4.64 years of fcf income to pay off all of its debts.
With a decent Debt to FCF ratio value of 4.64, CBHD is doing good in the industry, outperforming 65.52% of the companies in the same industry.
CBHD has a Debt/Equity ratio of 0.96. This is a neutral value indicating CBHD is somewhat dependend on debt financing.
CBHD's Debt to Equity ratio of 0.96 is on the low side compared to the rest of the industry. CBHD is outperformed by 77.59% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.96 | ||
| Debt/FCF | 4.64 | ||
| Altman-Z | 4.36 |
ROIC/WACC2.38
WACC6.56%
2.3 Liquidity
CBHD has a Current Ratio of 1.02. This is a normal value and indicates that CBHD is financially healthy and should not expect problems in meeting its short term obligations.
With a Current ratio value of 1.02, CBHD is not doing good in the industry: 70.69% of the companies in the same industry are doing better.
A Quick Ratio of 0.66 indicates that CBHD may have some problems paying its short term obligations.
CBHD has a worse Quick ratio (0.66) than 68.97% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.02 | ||
| Quick Ratio | 0.66 |
3. Growth
3.1 Past
The earnings per share for CBHD have decreased by -7.50% in the last year.
CBHD shows a small growth in Earnings Per Share. Measured over the last years, the EPS has been growing by 2.72% yearly.
The Revenue has grown by 8.89% in the past year. This is quite good.
Measured over the past years, CBHD shows a quite strong growth in Revenue. The Revenue has been growing by 8.54% on average per year.
EPS 1Y (TTM)-7.5%
EPS 3Y-0.25%
EPS 5Y2.72%
EPS Q2Q%-22.08%
Revenue 1Y (TTM)8.89%
Revenue growth 3Y11.64%
Revenue growth 5Y8.54%
Sales Q2Q%5.22%
3.2 Future
CBHD is expected to show quite a strong growth in Earnings Per Share. In the coming years, the EPS will grow by 11.30% yearly.
CBHD is expected to show a small growth in Revenue. In the coming years, the Revenue will grow by 6.41% yearly.
EPS Next Y14.67%
EPS Next 2Y13.5%
EPS Next 3Y13.5%
EPS Next 5Y11.3%
Revenue Next Year5.69%
Revenue Next 2Y6.84%
Revenue Next 3Y7.29%
Revenue Next 5Y6.41%
3.3 Evolution
The EPS growth rate is accelerating: in the next years the growth will be better than in the last years.
The Revenue growth rate is decreasing: in the next years the growth will be less than in the last years.
4. Valuation
4.1 Price/Earnings Ratio
Based on the Price/Earnings ratio of 30.91, the valuation of CBHD can be described as expensive.
CBHD's Price/Earnings ratio is a bit cheaper when compared to the industry. CBHD is cheaper than 63.79% of the companies in the same industry.
When comparing the Price/Earnings ratio of CBHD to the average of the S&P500 Index (26.25), we can say CBHD is valued inline with the index average.
CBHD is valuated rather expensively with a Price/Forward Earnings ratio of 22.16.
CBHD's Price/Forward Earnings ratio is a bit cheaper when compared to the industry. CBHD is cheaper than 63.79% of the companies in the same industry.
Compared to an average S&P500 Price/Forward Earnings ratio of 22.15, CBHD is valued at the same level.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.91 | ||
| Fwd PE | 22.16 |
4.2 Price Multiples
60.34% of the companies in the same industry are more expensive than CBHD, based on the Enterprise Value to EBITDA ratio.
Compared to the rest of the industry, the Price/Free Cash Flow ratio of CBHD indicates a somewhat cheap valuation: CBHD is cheaper than 75.86% of the companies listed in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | 27.65 | ||
| EV/EBITDA | 17.87 |
4.3 Compensation for Growth
The high PEG Ratio(NY), which compensates the Price/Earnings for growth, indicates an expensive valuation of the company.
The excellent profitability rating of CBHD may justify a higher PE ratio.
CBHD's earnings are expected to grow with 13.50% in the coming years. This may justify a more expensive valuation.
PEG (NY)2.11
PEG (5Y)11.37
EPS Next 2Y13.5%
EPS Next 3Y13.5%
5. Dividend
5.1 Amount
CBHD has a Yearly Dividend Yield of 3.40%.
Compared to an average industry Dividend Yield of 2.19, CBHD pays a better dividend. On top of this CBHD pays more dividend than 94.83% of the companies listed in the same industry.
CBHD's Dividend Yield is a higher than the S&P500 average which is at 2.40.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.4% |
5.2 History
The dividend of CBHD has a limited annual growth rate of 5.57%.
Dividend Growth(5Y)5.57%
Div Incr Years5
Div Non Decr Years5
5.3 Sustainability
CBHD pays out 109.07% of its income as dividend. This is not a sustainable payout ratio.
The dividend of CBHD is growing, but earnings are growing more, so the dividend growth is sustainable.
DP109.07%
EPS Next 2Y13.5%
EPS Next 3Y13.5%
FRA:CBHD (5/29/2025, 7:00:00 PM)
85.94
-0.56 (-0.65%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupHealth Care Equipment & Services
GICS IndustryHealth Care Equipment & Supplies
Earnings (Last)
Earnings (Next)
Inst Owners30.1%
Inst Owner ChangeN/A
Ins Owners35%
Ins Owner ChangeN/A
Market Cap18.06B
Analysts72.14
Price Target116.2 (35.21%)
Short Float %N/A
Short RatioN/A
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | 3.4% |
Yearly Dividend2.81
Dividend Growth(5Y)5.57%
DP109.07%
Div Incr Years5
Div Non Decr Years5
Ex-DateN/A
Surprises & Revisions
EPS beat(2)0
Avg EPS beat(2)-15.35%
Min EPS beat(2)-15.38%
Max EPS beat(2)-15.32%
EPS beat(4)0
Avg EPS beat(4)-9.27%
Min EPS beat(4)-15.38%
Max EPS beat(4)-0.34%
EPS beat(8)0
Avg EPS beat(8)-7.43%
EPS beat(12)1
Avg EPS beat(12)-6.85%
EPS beat(16)2
Avg EPS beat(16)-6.39%
Revenue beat(2)0
Avg Revenue beat(2)-0.99%
Min Revenue beat(2)-1.56%
Max Revenue beat(2)-0.41%
Revenue beat(4)1
Avg Revenue beat(4)-0.5%
Min Revenue beat(4)-1.56%
Max Revenue beat(4)0.01%
Revenue beat(8)1
Avg Revenue beat(8)-1.53%
Revenue beat(12)2
Avg Revenue beat(12)-1.09%
Revenue beat(16)4
Avg Revenue beat(16)-0.74%
PT rev (1m)-7.82%
PT rev (3m)-8%
EPS NQ rev (1m)-7.36%
EPS NQ rev (3m)-16.03%
EPS NY rev (1m)0%
EPS NY rev (3m)0.46%
Revenue NQ rev (1m)-2.13%
Revenue NQ rev (3m)-2.5%
Revenue NY rev (1m)-1.44%
Revenue NY rev (3m)-1.66%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | 30.91 | ||
| Fwd PE | 22.16 | ||
| P/S | 4.85 | ||
| P/FCF | 27.65 | ||
| P/OCF | 21.43 | ||
| P/B | 7.51 | ||
| P/tB | N/A | ||
| EV/EBITDA | 17.87 |
EPS(TTM)2.78
EY3.23%
EPS(NY)3.88
Fwd EY4.51%
FCF(TTM)3.11
FCFY3.62%
OCF(TTM)4.01
OCFY4.67%
SpS17.73
BVpS11.44
TBVpS-7.9
PEG (NY)2.11
PEG (5Y)11.37
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | 9.45% | ||
| ROE | 25.33% | ||
| ROCE | 19.74% | ||
| ROIC | 15.63% | ||
| ROICexc | 15.97% | ||
| ROICexgc | 87.72% | ||
| OM | 26.9% | ||
| PM (TTM) | 16.35% | ||
| GM | 67.52% | ||
| FCFM | 17.53% |
ROA(3y)11%
ROA(5y)18.91%
ROE(3y)37.52%
ROE(5y)45.66%
ROIC(3y)16.81%
ROIC(5y)28.33%
ROICexc(3y)17.22%
ROICexc(5y)29.72%
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)21.23%
ROCE(5y)39.82%
ROICexcg growth 3Y7.74%
ROICexcg growth 5Y2.01%
ROICexc growth 3Y-30.17%
ROICexc growth 5Y-21.96%
OM growth 3Y-6.25%
OM growth 5Y-2.74%
PM growth 3Y-9.04%
PM growth 5Y-2.84%
GM growth 3Y-0.46%
GM growth 5Y-0.05%
F-Score6
Asset Turnover0.58
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 0.96 | ||
| Debt/FCF | 4.64 | ||
| Debt/EBITDA | 1.96 | ||
| Cap/Depr | 105.92% | ||
| Cap/Sales | 5.09% | ||
| Interest Coverage | 8.47 | ||
| Cash Conversion | 71.35% | ||
| Profit Quality | 107.24% | ||
| Current Ratio | 1.02 | ||
| Quick Ratio | 0.66 | ||
| Altman-Z | 4.36 |
F-Score6
WACC6.56%
ROIC/WACC2.38
Cap/Depr(3y)114.16%
Cap/Depr(5y)140.02%
Cap/Sales(3y)5.02%
Cap/Sales(5y)6.04%
Profit Quality(3y)58.21%
Profit Quality(5y)66.95%
High Growth Momentum
Growth
EPS 1Y (TTM)-7.5%
EPS 3Y-0.25%
EPS 5Y2.72%
EPS Q2Q%-22.08%
EPS Next Y14.67%
EPS Next 2Y13.5%
EPS Next 3Y13.5%
EPS Next 5Y11.3%
Revenue 1Y (TTM)8.89%
Revenue growth 3Y11.64%
Revenue growth 5Y8.54%
Sales Q2Q%5.22%
Revenue Next Year5.69%
Revenue Next 2Y6.84%
Revenue Next 3Y7.29%
Revenue Next 5Y6.41%
EBIT growth 1Y6.6%
EBIT growth 3Y4.66%
EBIT growth 5Y5.57%
EBIT Next Year23.01%
EBIT Next 3Y14.31%
EBIT Next 5Y13.29%
FCF growth 1Y33.03%
FCF growth 3Y-24.77%
FCF growth 5Y-17.33%
OCF growth 1Y28.46%
OCF growth 3Y-19.49%
OCF growth 5Y-8.71%